Drugs / Umeta-mimi
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT04771728 | Feb 2020 → Dec 2026 expected | bacterial vaginosis | Peking University Shenzhen Hospital | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Umeta-mimi | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04771728 ↗ |
| Modality | Other / unclassified | “oral Probiotics(Umeta-mimi,30 days)” NCT04771728 ↗ |
| Route | Oral | “Oral Umeta-mimi( 5×109cfu per day,30 days）” NCT04771728 ↗ |